Hubungan Jumlah Sel Limfosit CD4+ dan CD8+ dengan Gambaran Klinis Kondiloma Akuminata
45
DAFTAR PUSTAKA
1. Winer RL, Koutsy LA. Genital human papilomavirus infection. Dalam: Holmes
KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen MS, Watts
DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York: McGraw
Hill; 2008.h.489-501
2. Murtiastutik D. Kondiloma akuminata. Dalam: Barakbah J, Lumintang H,
Martodihardjo S, penyunting. Buku Ajar Infeksi Menular Seksual. Surabaya:
Airlangga University Press; 2008.h.165-69
3. Zubier F. Kondiloma akuminata. Dalam: Daili FS, Makes BIN, Zubier F,
Judanarso J, penyunting. Infeksi Menular Seksual. Edisi ke-3. Jakarta: Balai
penerbit Fakultas Kedokteran Universitas Indonesia;2005.h.126-31
4. Center for Disease Control and Prevention. Sexually Transmitted Disease
Treatment Guidelines 2010. Morbidity and Mortality Weekly Report.2010;59: 6978
5. Monk BJ, Tewari KS. The spectrum and clinical sequellae of human
papillomavirus infection. Gynecol Oncol.2007;107(2 Suppl 1):S6-13
6. Steben M, Duarte-Franco E. Human papillomavrus infection: Epidemiology and
pathophysiology. Gynecol Oncol.2007;107(2 Suppl 1):S2-5.
7. Alba A, Cararach M, RRodriquez-Cerdeira C. The human papillomavirus (HPV)
in human pathology; description, pathogenesis, oncogenic role, epidemiology and
detection technique. The Open Dermatology Journal.2009;3:90-102
8. Hakim L. Biologi dan patogenesis human papiloma virus. PKB “New perspective
of sexually transmitted infection problems. Surabaya;2010.h.164-80
9. Herbert C, Melgert B, Laan JW, Faas M. New adjuvantes vaccines in pregnancy:
what is known about their safety? Expert Rev Vaccines.2010; 9(12): 1411-22
10. Monia M, Fethi BA, Asma F, Hedi R. Giant condyloma in pregnancy. La Tunisie
Medicale.2013;91:422-3
11. Goncalves MAG, Donadi EA. Immune cellular response to HPV: current
concepts. Braz J Infect.2004; 8(1):1-9
12. Stanley MA. Immune responses to human papilloma viruses. Indian J Med Res.
2009;130:266-76
13. Leto MGP, Santor Jr GF, Poro AM, Tomimori J. Human papillomavirus
infection: etiopathogenesis, molecular biology and clinical manifestations. An
Bras Dermatol.2011; 86(2): 306-17
14. Xu Y, Zhu KJ, Zhu N, Chen XZ, Cheng H. Expression of Foxp3+ CD4+ CD25+
regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of
patients with condyloma acuminatum. Clinical and Experimental Dermatology.
2008; 34: 229-35
15. Ljubojevic S, LipozencicGrgec DL, Prstatic R, Skerlev M, Mokos ZB. Human
Papilloma Virus associated with genital infection. Coll Antropol.2008;32(3):98997
16. Nelwan SR, Niode NJ, Kapantow MG. Profil kondiloma akuminata di Poliklinik
Kulit dan Kelamin RSUP. Prof. Dr.R.D. Kandou Manado Januari 2012-
Universitas Sumatera Utara
46
Desember 2012. Skripsi Fakultas Kedokteran Universitas Sam Ratulangi Manado
Bagian/SMF Kulit dan Kelamin RSUP Prof. Dr.R.D. Kandou Manado.2014
17. Adriman Z, Rangkuti IF, Nadeak K. Karakteristik pasien kutil kelamin di RSUD.
Dr. Pirngadi Medan 2010-2012. Tesis Magister Fakultas Kedokteran Universitas
Sumatera Utara.2014
18. Silitonga JT. Gambaran infeksi menular seksual di RRSUP. H. Adam Malik
Medan tahun 2009. Karya Tulis Ilmiah Fakultas Kedokteran Universitas
Sumatera Utara. 2011
19. Androphy EJ, Lowy DR. Warts. Dalam: Wolff K, Goldsmith LA, Katz SI,
Gilchrest BA, Paller AS, Leffel DJ, penyunting. Fitzpatrick’s Dermatology in
General medicine. Edisi ke-7. New York: McGraw Hill; 2008.h.1914-22
20. Dyment PG. Human Papillomavirus. Adolesent medicine: State of the Art
Review.1996;7:167-73
21. Forcier M, Mussachhio N. An overview of human papillomavirus infection for
the dermatologist: disease, diagnosis, management and prevention. Dermatologic
therapy.2010;23:458-76
22. Man S. Human cellular immune responses against human papilloma viruses in
cervical neoplasia. Expert Reviews in Molecular Medicine. 1998;1998:1-18
23. Sanclemente G, Gill DK. Human papillomavirus molecular biology and
pathogenesis. J Eur Acad Dermatol Venereol.2002;16(3):231-40
24. Conway MJ, Meyers C. Replication and assembly of Human papillomaviruses. J
Dent Res.2009; 88(4): 307-17
25. Burd EM. Human papillomavirus and cervical cancer. Clin Micr Rev.
2003;16(1):1-17
26. Scheurer ME, Tortolero-Luna G, Adler-Storhz K. Human papillomavirus
infection: biology, epidemiology and prevention. Int J Gynecol
Cancer.2005;15:727-46
27. Bergot AS, Kassianos A, Frazer IH, Mittal D. New approaches to immunotherapy
for HPV associated cancers. Cancers. 2011;3:3461-95
28. Egelkrout, Galloway DA. The biology of genital human papillomavirus. Dalam:
Holmes KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen
MS, Watts DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York:
McGraw Hill; 2008.h.463-89
29. Frazer IH. Interaction of human papillomaviruses with the host immune system:
A well evolved relationship. Virology. 2009;384:410-14
30. Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review.
Australian
and
New
Zealand
journal
of
obstetrics
and
gynaecology.2011;5(2):103-8
31. Kihara A, Kosgei JR, Rogena E, Amin M, Cheserem JE, Kiarie J. Vulvo-perianal
giant condyloma accuminata (Buschke Loweinstein Tumor) in a HIV-infected
woman: a case report. JOGECA.2012;24(2): 52-4
32. Yakasai IA, Abu Bakar IS, Ibrahim SA, Ayyuba R. Unusaul presentation of giant
condyloma acuminate of the vulva- A case report and review literature. Anatom
physiol. 2012; 86: 1-3
Universitas Sumatera Utara
47
33. Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection
in men: what does it add?. JEADV. 2001; 15: 27-9
34. Dias EP, Gouvea ALF, Eyer CL. Condyloma acuminatum: its histopathological
pattern. Sao Paulo Medical Journal.1997; 115(2): 1383-9
35. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus
infections. Journal of clinical virology. 2005; 32: s16-24
36. Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical
protection and new approaches for the future. Journal of translational
medicine.2010;105:1-8
37. Heideman DAM, Snijders PJF, Berkhof J, Verheijen RHM, Helmerhorst TJM,
Meijer CJLM. Vaccination against HPV: indications for women and the impact
on cervical screening programme. BJOG.2008;115:938-46
38. Zajac AJ, Harrington LE. Immune response to viruses: cell-mediated immunity.
Encyclopedia of Virology. 2008; 3: 70-7
39. Baratawidjaja KG, Rengganis I. Gambaran sistem imun. Dalam: Imunologi
Dasar. Edisi ke-8. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas
Indonesia; 2009.h.27-56
40. Silling S, Wieland U, Werner M, Pfister H, Potthoff A, Kreuter A. Resolution of
novel human papillomavirus induced warts after HPV vaccination. Emerging
Infectious Diseases.2014;20(1):142-5
41. Bosire EM, Nyamache AK, Gicheru MM, Khamadi SA, Lihaha RW, Okoth V.
Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets
among healthy Kenyans. AIDS Research and Therapy.2013;10(24):1-7
42. Abdelrazaq AA, Yousif WH, Wohaieb SA. Flow cytometric analysis of CD4 and
CD8 cell subsets in some Iraqi patients with diabetes mellitus type 2. Current
Research in Microbiology and Biotechnology. 2013;1(5):235-8
43. Hong K, Greer CE, Ketter N, Van Nest G, Paliard X. Isolation and
characterization of human papillomavirus type 6 specific T cells infiltrating
genital warts. J Virol. 1997; 71(9): 6427-32
44. Stanley MA. Epithelial cell responses to infection with human papillomavirus.
Clinical Microbiology Reviews.2012;25(2): 215-22
45. Leiding JW, Holland SM. Warts and All: HPV in primary immunodeficiencies. J
Allergy Clin Immunol.2012;130(5):1030-48
46. Meliala SU. Respon imunitas seluler pada penderita kondiloma akuminata yang
sudah lama diderita. Tesis. Bagian Ilmu Kesehatan Kulit dan Kelamin FK USU.
2005
47. Israita P, Lumintang H, Murtiatutik D. Profil penderira baru kondiloma
akuminata di Divisi Penyakit Menular bSeksual URJ Kesehatan Kulit dan
Kelamin RSUD Dr. Soetomo Surabaya periode 2006-2008. Berkala Ilmu
Kesehatan Kulit dan Kelamin. 2011;23(3):216-21
48. Hidayat T. Deteksi Human papilloma virus tipe 6 dan 11 pada lesi dan peri lesi
kondiloma akuminatum dengan polymerase chain reaction. Tesis. Bagian Ilmu
Kesehatan Kulit dan Kelamin FK Universitas Andalas. 2012
Universitas Sumatera Utara
48
49. Kyriakis KP, Hadjivvassiliou M, Paparizos VA, Riga P, Katsamba A.
Determinants of genital wart case detection rates among STD clinic attendees in
Athens, Greece. Int J Dermatol. 2005;44:650-3
50. Chang GJ, Welton ML. Human papillomavirus, condyloma acuminate and anal
neoplasia. Clin colon rectal surg.2004;17(4):221-30
51. Sung JH, Ahn EJ, Oh H, Park SH. Association of immune status recurrent anal
condylomata in human immunodeficiency virus-positive patients. J Korean Suc
Colorectal. 2012;78(1):294-8
52. Thappa DM, Senthilkumar M, Laxmisha C. Anogenital wart-an overview. Indian
J Sex Transm Dis. 2004;25(2):55-66
53. Krebs HB, Denny L. Human papillomavirus infection and genital tract cancer.
The Global Library of Women S Medicine. Diunduh dari:
www.glown.com/section_view/heading/Human%20Papillomavirus%20Infection
%20and%20Genital%20Tract%20Cancer/item/226#sectionView. Pada tanggal 2
April 2016
54. Castellsague X, Cohet C, Puig-Tintore L, Acebes LO, Salinas J, Martin MS et all.
Epidemiology and cost of treatment of genital warts in Spain. European Journal
of Public Helath. 2008;19(1):106-10
55. Untung SP. Kondiloma akuminatum penyakit hubungan seksual penyerta dan
respon imun seluler. Laporan penelitian. Program Pendidikan Dokter Spesialis
Ilmu Penyakit Kulit dan Kelamin FK UI. 1988
56. Dong-Xian L, Wen J, Xing-ping C, Ying-ling C, Dong-liang Y. Expression of
cytokine in CD8+ T lymphocyte of the peripheral blood of patients with
condyloma acuminatum. Chinese Journal of Dermatology. 2007;40(11):674-5
57. Stanley M. Immune responses to human papillomavirus. JVAD. 2006;24(1):21622
58. Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonre JP, Dupin N. Imiquimod
5% cream for external genital or perianal warts in human immunodeficiency
virus- positive patients treated with highly active antiretroviral therapy: an openlabel, non comparative study. BJD. 2009;161:904-9
59. Hibma MH. The immune response to papillomavirus during infection persistence
and regression. The Open Virology Journal. 2012;6(2):241-8
60. Luu HN, Amirian ES, Chan W, Beasley RP, Piller LB, Scheuner ME. Cd4+ cell
count and HIV load as predictors of size of anal warts over time in HIV infected
women. JID. 2012;205:579-85
61. Opaneye AA. The cellular immune system in female patients with or without
genital warts: a study of peripheral white blood cell components. International
journal of STD & AIDS. 1999;10:815-6
62. Nambudiri VE, Mutyambizi K, Walls AC, Fisher DC, Bleday R, Saavedra AP.
Successful treatment of perianal giant condyloma acuminatum in an
immunocompromised host with systemic interleukin 2 an topical cidofovir. JAMA
Dermatol. 2013;149(9):1068-70
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. Winer RL, Koutsy LA. Genital human papilomavirus infection. Dalam: Holmes
KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen MS, Watts
DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York: McGraw
Hill; 2008.h.489-501
2. Murtiastutik D. Kondiloma akuminata. Dalam: Barakbah J, Lumintang H,
Martodihardjo S, penyunting. Buku Ajar Infeksi Menular Seksual. Surabaya:
Airlangga University Press; 2008.h.165-69
3. Zubier F. Kondiloma akuminata. Dalam: Daili FS, Makes BIN, Zubier F,
Judanarso J, penyunting. Infeksi Menular Seksual. Edisi ke-3. Jakarta: Balai
penerbit Fakultas Kedokteran Universitas Indonesia;2005.h.126-31
4. Center for Disease Control and Prevention. Sexually Transmitted Disease
Treatment Guidelines 2010. Morbidity and Mortality Weekly Report.2010;59: 6978
5. Monk BJ, Tewari KS. The spectrum and clinical sequellae of human
papillomavirus infection. Gynecol Oncol.2007;107(2 Suppl 1):S6-13
6. Steben M, Duarte-Franco E. Human papillomavrus infection: Epidemiology and
pathophysiology. Gynecol Oncol.2007;107(2 Suppl 1):S2-5.
7. Alba A, Cararach M, RRodriquez-Cerdeira C. The human papillomavirus (HPV)
in human pathology; description, pathogenesis, oncogenic role, epidemiology and
detection technique. The Open Dermatology Journal.2009;3:90-102
8. Hakim L. Biologi dan patogenesis human papiloma virus. PKB “New perspective
of sexually transmitted infection problems. Surabaya;2010.h.164-80
9. Herbert C, Melgert B, Laan JW, Faas M. New adjuvantes vaccines in pregnancy:
what is known about their safety? Expert Rev Vaccines.2010; 9(12): 1411-22
10. Monia M, Fethi BA, Asma F, Hedi R. Giant condyloma in pregnancy. La Tunisie
Medicale.2013;91:422-3
11. Goncalves MAG, Donadi EA. Immune cellular response to HPV: current
concepts. Braz J Infect.2004; 8(1):1-9
12. Stanley MA. Immune responses to human papilloma viruses. Indian J Med Res.
2009;130:266-76
13. Leto MGP, Santor Jr GF, Poro AM, Tomimori J. Human papillomavirus
infection: etiopathogenesis, molecular biology and clinical manifestations. An
Bras Dermatol.2011; 86(2): 306-17
14. Xu Y, Zhu KJ, Zhu N, Chen XZ, Cheng H. Expression of Foxp3+ CD4+ CD25+
regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of
patients with condyloma acuminatum. Clinical and Experimental Dermatology.
2008; 34: 229-35
15. Ljubojevic S, LipozencicGrgec DL, Prstatic R, Skerlev M, Mokos ZB. Human
Papilloma Virus associated with genital infection. Coll Antropol.2008;32(3):98997
16. Nelwan SR, Niode NJ, Kapantow MG. Profil kondiloma akuminata di Poliklinik
Kulit dan Kelamin RSUP. Prof. Dr.R.D. Kandou Manado Januari 2012-
Universitas Sumatera Utara
46
Desember 2012. Skripsi Fakultas Kedokteran Universitas Sam Ratulangi Manado
Bagian/SMF Kulit dan Kelamin RSUP Prof. Dr.R.D. Kandou Manado.2014
17. Adriman Z, Rangkuti IF, Nadeak K. Karakteristik pasien kutil kelamin di RSUD.
Dr. Pirngadi Medan 2010-2012. Tesis Magister Fakultas Kedokteran Universitas
Sumatera Utara.2014
18. Silitonga JT. Gambaran infeksi menular seksual di RRSUP. H. Adam Malik
Medan tahun 2009. Karya Tulis Ilmiah Fakultas Kedokteran Universitas
Sumatera Utara. 2011
19. Androphy EJ, Lowy DR. Warts. Dalam: Wolff K, Goldsmith LA, Katz SI,
Gilchrest BA, Paller AS, Leffel DJ, penyunting. Fitzpatrick’s Dermatology in
General medicine. Edisi ke-7. New York: McGraw Hill; 2008.h.1914-22
20. Dyment PG. Human Papillomavirus. Adolesent medicine: State of the Art
Review.1996;7:167-73
21. Forcier M, Mussachhio N. An overview of human papillomavirus infection for
the dermatologist: disease, diagnosis, management and prevention. Dermatologic
therapy.2010;23:458-76
22. Man S. Human cellular immune responses against human papilloma viruses in
cervical neoplasia. Expert Reviews in Molecular Medicine. 1998;1998:1-18
23. Sanclemente G, Gill DK. Human papillomavirus molecular biology and
pathogenesis. J Eur Acad Dermatol Venereol.2002;16(3):231-40
24. Conway MJ, Meyers C. Replication and assembly of Human papillomaviruses. J
Dent Res.2009; 88(4): 307-17
25. Burd EM. Human papillomavirus and cervical cancer. Clin Micr Rev.
2003;16(1):1-17
26. Scheurer ME, Tortolero-Luna G, Adler-Storhz K. Human papillomavirus
infection: biology, epidemiology and prevention. Int J Gynecol
Cancer.2005;15:727-46
27. Bergot AS, Kassianos A, Frazer IH, Mittal D. New approaches to immunotherapy
for HPV associated cancers. Cancers. 2011;3:3461-95
28. Egelkrout, Galloway DA. The biology of genital human papillomavirus. Dalam:
Holmes KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen
MS, Watts DH, penyunting. Sexually Transmitted Disease. Edisi ke-4. New York:
McGraw Hill; 2008.h.463-89
29. Frazer IH. Interaction of human papillomaviruses with the host immune system:
A well evolved relationship. Virology. 2009;384:410-14
30. Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review.
Australian
and
New
Zealand
journal
of
obstetrics
and
gynaecology.2011;5(2):103-8
31. Kihara A, Kosgei JR, Rogena E, Amin M, Cheserem JE, Kiarie J. Vulvo-perianal
giant condyloma accuminata (Buschke Loweinstein Tumor) in a HIV-infected
woman: a case report. JOGECA.2012;24(2): 52-4
32. Yakasai IA, Abu Bakar IS, Ibrahim SA, Ayyuba R. Unusaul presentation of giant
condyloma acuminate of the vulva- A case report and review literature. Anatom
physiol. 2012; 86: 1-3
Universitas Sumatera Utara
47
33. Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection
in men: what does it add?. JEADV. 2001; 15: 27-9
34. Dias EP, Gouvea ALF, Eyer CL. Condyloma acuminatum: its histopathological
pattern. Sao Paulo Medical Journal.1997; 115(2): 1383-9
35. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus
infections. Journal of clinical virology. 2005; 32: s16-24
36. Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical
protection and new approaches for the future. Journal of translational
medicine.2010;105:1-8
37. Heideman DAM, Snijders PJF, Berkhof J, Verheijen RHM, Helmerhorst TJM,
Meijer CJLM. Vaccination against HPV: indications for women and the impact
on cervical screening programme. BJOG.2008;115:938-46
38. Zajac AJ, Harrington LE. Immune response to viruses: cell-mediated immunity.
Encyclopedia of Virology. 2008; 3: 70-7
39. Baratawidjaja KG, Rengganis I. Gambaran sistem imun. Dalam: Imunologi
Dasar. Edisi ke-8. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas
Indonesia; 2009.h.27-56
40. Silling S, Wieland U, Werner M, Pfister H, Potthoff A, Kreuter A. Resolution of
novel human papillomavirus induced warts after HPV vaccination. Emerging
Infectious Diseases.2014;20(1):142-5
41. Bosire EM, Nyamache AK, Gicheru MM, Khamadi SA, Lihaha RW, Okoth V.
Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets
among healthy Kenyans. AIDS Research and Therapy.2013;10(24):1-7
42. Abdelrazaq AA, Yousif WH, Wohaieb SA. Flow cytometric analysis of CD4 and
CD8 cell subsets in some Iraqi patients with diabetes mellitus type 2. Current
Research in Microbiology and Biotechnology. 2013;1(5):235-8
43. Hong K, Greer CE, Ketter N, Van Nest G, Paliard X. Isolation and
characterization of human papillomavirus type 6 specific T cells infiltrating
genital warts. J Virol. 1997; 71(9): 6427-32
44. Stanley MA. Epithelial cell responses to infection with human papillomavirus.
Clinical Microbiology Reviews.2012;25(2): 215-22
45. Leiding JW, Holland SM. Warts and All: HPV in primary immunodeficiencies. J
Allergy Clin Immunol.2012;130(5):1030-48
46. Meliala SU. Respon imunitas seluler pada penderita kondiloma akuminata yang
sudah lama diderita. Tesis. Bagian Ilmu Kesehatan Kulit dan Kelamin FK USU.
2005
47. Israita P, Lumintang H, Murtiatutik D. Profil penderira baru kondiloma
akuminata di Divisi Penyakit Menular bSeksual URJ Kesehatan Kulit dan
Kelamin RSUD Dr. Soetomo Surabaya periode 2006-2008. Berkala Ilmu
Kesehatan Kulit dan Kelamin. 2011;23(3):216-21
48. Hidayat T. Deteksi Human papilloma virus tipe 6 dan 11 pada lesi dan peri lesi
kondiloma akuminatum dengan polymerase chain reaction. Tesis. Bagian Ilmu
Kesehatan Kulit dan Kelamin FK Universitas Andalas. 2012
Universitas Sumatera Utara
48
49. Kyriakis KP, Hadjivvassiliou M, Paparizos VA, Riga P, Katsamba A.
Determinants of genital wart case detection rates among STD clinic attendees in
Athens, Greece. Int J Dermatol. 2005;44:650-3
50. Chang GJ, Welton ML. Human papillomavirus, condyloma acuminate and anal
neoplasia. Clin colon rectal surg.2004;17(4):221-30
51. Sung JH, Ahn EJ, Oh H, Park SH. Association of immune status recurrent anal
condylomata in human immunodeficiency virus-positive patients. J Korean Suc
Colorectal. 2012;78(1):294-8
52. Thappa DM, Senthilkumar M, Laxmisha C. Anogenital wart-an overview. Indian
J Sex Transm Dis. 2004;25(2):55-66
53. Krebs HB, Denny L. Human papillomavirus infection and genital tract cancer.
The Global Library of Women S Medicine. Diunduh dari:
www.glown.com/section_view/heading/Human%20Papillomavirus%20Infection
%20and%20Genital%20Tract%20Cancer/item/226#sectionView. Pada tanggal 2
April 2016
54. Castellsague X, Cohet C, Puig-Tintore L, Acebes LO, Salinas J, Martin MS et all.
Epidemiology and cost of treatment of genital warts in Spain. European Journal
of Public Helath. 2008;19(1):106-10
55. Untung SP. Kondiloma akuminatum penyakit hubungan seksual penyerta dan
respon imun seluler. Laporan penelitian. Program Pendidikan Dokter Spesialis
Ilmu Penyakit Kulit dan Kelamin FK UI. 1988
56. Dong-Xian L, Wen J, Xing-ping C, Ying-ling C, Dong-liang Y. Expression of
cytokine in CD8+ T lymphocyte of the peripheral blood of patients with
condyloma acuminatum. Chinese Journal of Dermatology. 2007;40(11):674-5
57. Stanley M. Immune responses to human papillomavirus. JVAD. 2006;24(1):21622
58. Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonre JP, Dupin N. Imiquimod
5% cream for external genital or perianal warts in human immunodeficiency
virus- positive patients treated with highly active antiretroviral therapy: an openlabel, non comparative study. BJD. 2009;161:904-9
59. Hibma MH. The immune response to papillomavirus during infection persistence
and regression. The Open Virology Journal. 2012;6(2):241-8
60. Luu HN, Amirian ES, Chan W, Beasley RP, Piller LB, Scheuner ME. Cd4+ cell
count and HIV load as predictors of size of anal warts over time in HIV infected
women. JID. 2012;205:579-85
61. Opaneye AA. The cellular immune system in female patients with or without
genital warts: a study of peripheral white blood cell components. International
journal of STD & AIDS. 1999;10:815-6
62. Nambudiri VE, Mutyambizi K, Walls AC, Fisher DC, Bleday R, Saavedra AP.
Successful treatment of perianal giant condyloma acuminatum in an
immunocompromised host with systemic interleukin 2 an topical cidofovir. JAMA
Dermatol. 2013;149(9):1068-70
Universitas Sumatera Utara